Sarcoma / 2017 / Article / Fig 2

Research Article

High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma

Figure 2

Overall survival (OS) of patients treated with high-dose prolonged-infusion ifosfamide chemotherapy (11 patients). Median OS was 37 months.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.